Table 1.
Patient characteristics
| Characteristics | Data |
|---|---|
| Patients (n) | 44 |
| Sex (n) | |
| Men | 24 (55%) |
| Women | 20 (45%) |
| Age (y) | 60 [53–66] |
| Body mass index (kg/m2) | 28 ± 4 |
| Previous clinically documented ASCVD* | |
| Coronary revascularization† | 6 (14%) |
| Myocardial infarction | 5 (11%) |
| Stroke and transient ischemic attack | 2 (5%) |
| Peripheral arterial disease | 2 (5%) |
| Statin therapy (n) | 8 (18%) |
| Acetylsalicylic acid treatment | 10 (23%) |
| Systemic inflammatory disease | |
| Rheumatoid arthritis | 1 (2%) |
| Ulcerous-hemorrhagic recto-colitis | 1 (2%) |
| Cardiovascular risk factors (n) | |
| Arterial hypertension | 13 (30%) |
| Hypercholesterolemia | 12 (27%) |
| Smoking (current or former) | 19 (43%) |
| Diabetes mellitus | 4 (9%) |
| Type of disease (n) | |
| Head and neck tumors | 10 (23%) |
| Melanoma | 10 (23%) |
| Esophagus carcinoma | 6 (14%) |
| Carotid endarterectomy | 5 (11%) |
| Lung carcinoma | 2 (5%) |
| B-cell lymphoma | 2 (5%) |
| Ovarian cancer | 2 (5%) |
| Pancreatic cancer | 2 (5%) |
| Stomach cancer | 2 (5%) |
| Leiomyosarcoma | 1 (2%) |
| Breast cancer | 1 (2%) |
| Glioma | 1 (2%) |
*ASCVD: atherosclerotic cardiovascular disease
†Percutaneous coronary intervention or coronary artery bypass graft surgery